ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,242,797 | +51.4% | 193,176 | +71.5% | 0.03% | +52.4% |
| Q2 2023 | $3,462,492 | +187.4% | 112,638 | +236.9% | 0.02% | +200.0% |
| Q1 2023 | $1,204,735 | -22.0% | 33,437 | -14.5% | 0.01% | -12.5% |
| Q4 2022 | $1,544,955 | -37.8% | 39,093 | -36.8% | 0.01% | -38.5% |
| Q3 2022 | $2,485,000 | +1014.3% | 61,852 | +1065.0% | 0.01% | +1200.0% |
| Q2 2022 | $223,000 | -85.9% | 5,309 | -86.9% | 0.00% | -83.3% |
| Q1 2022 | $1,577,000 | +588.6% | 40,487 | +604.4% | 0.01% | +500.0% |
| Q4 2021 | $229,000 | -69.5% | 5,748 | -68.7% | 0.00% | -80.0% |
| Q2 2021 | $752,000 | +11.1% | 18,347 | +35.6% | 0.01% | -16.7% |
| Q4 2020 | $677,000 | – | 13,535 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $338,436,000 | 92.73% |
| Vantage Consulting Group Inc | 21,477,282 | $1,074,938,000 | 87.53% |
| Memorial Sloan Kettering Cancer Center | 3,565,887 | $178,473,000 | 75.56% |
| HARVARD MANAGEMENT CO INC | 14,690,780 | $735,274,000 | 39.88% |
| ROBERT WOOD JOHNSON FOUNDATION | 3,958,498 | $1,981,228,000 | 21.69% |
| Brown University | 381,759 | $19,107,000 | 13.82% |
| Overbrook Management Corp | 778,511 | $38,964,000 | 9.50% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 38,714,280 | $1,937,650,000 | 4.22% |
| Lagoda Investment Management, L.P. | 96,885 | $4,849,000 | 2.61% |
| HealthCor Management, L.P. | 1,339,530 | $67,043,000 | 2.58% |